[144] Satellogic Inc. SEC Filing

Rhea-AI Filing Summary

Satellogic Inc. notice reports a proposed Rule 144 sale of 85,700 common shares held as founders' shares, with an aggregate market value of $311,091 based on the filing. The shares were acquired on 01/26/2022 as founders' shares from the issuer and the planned sale is listed as approximately 10/08/2025 on the NASDAQ. The filing lists the executing broker as Morgan Stanley Smith Barney LLC.

The form also discloses multiple recent open-market sales by the same holder between 08/26/2025 and 09/23/2025, totaling large share disposals (examples include 435,956 shares for $1,716,271.58 on 09/12/2025 and 209,413 shares for $806,135.34 on 09/15/2025). The signer represents no undisclosed material adverse information and notes possible reliance on a Rule 10b5-1 plan for some sales.

Positive

• Planned sale is disclosed under Rule 144, providing regulatory transparency
• Brokered through Morgan Stanley Smith Barney, suggesting an institutional execution channel
• Filer represented no undisclosed material adverse information when signing the notice

Negative

• Multiple large recent sales by the same holder between 08/26/2025 and 09/23/2025 indicate ongoing share disposals
• Aggregate proceeds shown (e.g., $1,716,271.58 on 09/12/2025) point to meaningful supply into the market in recent weeks
• Founders' shares being sold may increase public float and exert short-term downward pressure on the stock

Insights

Securities Compliance Analyst

TL;DR: Proposed Rule 144 sale of 85,700 founders' shares, with recent large 10b5-1 and open-market disposals by the same holder.

The notice documents a standard Rule 144 disposition: 85,700 common shares acquired as founders' shares on 01/26/2022 and planned for sale around 10/08/2025

Key dependencies include the availability of unrestricted shares under Rule 144 and any timing or volume limits tied to a broker or a 10b5-1 trading plan. Recent sales listed from 08/26/2025 to 09/23/2025 show active dispositions that may relate to the same compliance framework; monitor filing-confirmed plan adoption dates to confirm protection from insider-trading claims.

Equity Markets Analyst

TL;DR: Holder has been selling sizable blocks in recent weeks; the planned 85,700-share sale is modest relative to recent disposals but still dilutive to free float near-term.

Recent disclosed sales include individual trades of 435,956 and 209,413 shares with multi-hundred-thousand dollar proceeds, indicating meaningful liquidity contribution from this holder. The scheduled 10/08/2025 sale of 85,700 shares equals ~0.09% of the 94,985,681 shares outstanding reported in the filing, so market impact per trade may be limited but cumulative sales have been material.

Watch short-term volume and price around 10/08/2025 and any further filings that state whether the sale is executed under a 10b5-1 plan, as that affects predictability of future supply.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85700	311091.00	94985681	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/26/2022	Founders Shares	Issuer			85700	01/26/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/23/2025	130	520.00
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/16/2025	17380	65175.00
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/15/2025	209413	806135.34
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/12/2025	435956	1716271.58
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/11/2025	60416	227780.40
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/10/2025	80951	304910.04
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/09/2025	1149	4308.75
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	09/03/2025	76685	287967.51
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	08/29/2025	29770	111637.50
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	08/27/2025	15191	56966.25
EMILIANO KARGIEMAN 210 Delburg Street Davidson NC 28036	Common	08/26/2025	73089	274083.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Satellogic (SATL) disclose?

The filing shows a proposed Rule 144 sale of 85,700 common shares valued at $311,091, acquired as founders' shares on 01/26/2022, with an approximate sale date of 10/08/2025.

Who is the broker handling the proposed SATL sale?

The broker named is Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY.

Has the filer sold shares recently for SATL?

Yes. The filing lists multiple sales between 08/26/2025 and 09/23/2025, including 435,956 shares for $1,716,271.58 on 09/12/2025.

When were the shares being sold originally acquired?

The 85,700 shares were acquired as founders' shares from the issuer on 01/26/2022.

Does the filer claim reliance on a Rule 10b5-1 plan?

The filing references that some sales were under a 10b5-1 plan (noting a 10b5-1 sale on 09/23/2025), but the form does not include a specific plan adoption date in the visible fields.